Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
6.42B | 8.62B | 8.74B | 7.51B | 3.45B | 4.16B | Gross Profit |
2.70B | 3.83B | 4.09B | 3.35B | 842.00M | 1.36B | EBIT |
889.00M | 1.73B | 2.13B | 1.75B | -448.00M | -86.00M | EBITDA |
843.50M | 1.80B | 2.20B | 1.80B | -402.00M | -29.00M | Net Income Common Stockholders |
886.00M | 1.51B | 2.25B | 1.72B | -290.00M | -168.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
4.21B | 4.69B | 3.86B | 2.61B | 3.25B | 199.00M | Total Assets |
15.95B | 16.16B | 14.34B | 12.89B | 10.34B | 10.20B | Total Debt |
376.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Debt |
-3.06B | -3.86B | -3.14B | -2.49B | -3.25B | -2.77B | Total Liabilities |
1.56B | 1.68B | 1.43B | 1.59B | 828.00M | 509.00M | Stockholders Equity |
14.39B | 14.48B | 12.91B | 11.30B | 9.51B | 9.60B |
Cash Flow | Free Cash Flow | ||||
0.00 | 576.00M | 1.30B | -152.00M | 506.00M | 472.00M | Operating Cash Flow |
0.00 | 871.00M | 1.45B | -117.00M | 542.00M | 478.00M | Investing Cash Flow |
0.00 | 149.00M | -117.00M | -825.00M | 30.00M | -115.00M | Financing Cash Flow |
0.00 | -691.00M | -676.00M | -58.00M | -112.00M | -296.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $6.13T | 38.89 | 34.01% | 0.48% | 60.27% | 158.92% | |
81 Outperform | $11.57T | 20.13 | 29.69% | 2.45% | 32.83% | 50.73% | |
77 Outperform | $5.27T | 29.52 | 8.97% | 0.72% | -1.55% | 17.24% | |
74 Outperform | ¥2.98T | 16.95 | 2.08% | 4.80% | 34.01% | ||
73 Outperform | ¥3.55T | 24.37 | 2.62% | 0.23% | 12.16% | ||
72 Outperform | ¥9.35B | 21.24 | 4.23% | -25.41% | -45.60% | ||
62 Neutral | $11.97B | 10.08 | -7.46% | 2.96% | 7.37% | -8.22% |